Oct 20, 2024, 10:56
Guillermo Villacampa: The safety and efficacy of ADCs with immunotherapy
“Antibody-drug conjugate (ADCs) in combination with immunotherapy is emerging as a promising strategy. However, concerns arise regarding the safety.
In this work, we present a combined analysis evaluating the safety and efficacy of this combination.”
Authors: Pablo Cresta Morgado, Lorenzo Carità, Victor Navarro, Tomas Pascual and Rodrigo Dienstmann.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 14:06
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33